RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma.

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• The RNA helicase DDX3X (DDX3) is a potential therapeutic target in Ewing sarcoma (EWS).
• The precise biological function of DDX3 in EWS remains incompletely understood.
• Understanding DDX3's role is crucial for developing targeted therapies.

Purpose of the Study:

• To elucidate the role of DDX3 in DNA damage repair (DDR) mechanisms within Ewing sarcoma.
• To investigate the interaction of DDX3 with key proteins involved in homologous recombination.
• To determine the impact of DDX3 inhibition on cellular responses to DNA damage and radiation.

Main Methods:

• Immunofluorescence and co-localization studies to visualize DDX3, RAD51, and RNA:DNA hybrids.
• Assessment of RAD51 nuclear translocation following DDX3 inhibition.
• Evaluation of Ewing sarcoma cell sensitivity to radiation treatment in vitro and in vivo.

Main Results:

• DDX3 interacts with homologous recombination proteins like RAD51, RECQL1, RPA32, and XRCC2.
• DDX3 colocalizes with RAD51 and RNA:DNA hybrids in the cytoplasm of EWS cells.
• Inhibition of DDX3's helicase activity increases cytoplasmic RNA:DNA hybrids, trapping RAD51 and hindering its nuclear repair function, thereby sensitizing EWS cells to radiation.

Conclusions:

• DDX3 plays a unique and critical role in regulating DNA damage repair pathways in Ewing sarcoma.
• DDX3 influences the localization of RAD51, a key protein in homologous recombination, by modulating cytoplasmic RNA:DNA hybrids.
• Targeting DDX3 activity offers a novel therapeutic strategy to enhance the efficacy of radiation treatment for Ewing sarcoma by manipulating DNA repair protein localization.